Literature DB >> 23546871

In vitro culture, determination, and directed differentiation of adult adipose-derived stem cells towards cardiomyocyte-like cells induced by angiotensin II.

Kedong Song1, Zhaomin Wang, Wenfang Li, Chao Zhang, Mayasari Lim, Tianqing Liu.   

Abstract

The in vitro basic biological characteristics and directed differentiation potential towards cardiomyocytes of adult adipose-derived stem cells (ADSCs) induced by angiotensin II were both investigated. ADSCs were isolated from adult adipose tissue and cultured in vitro, and were subsequently induced into adipocytes, chondrocytes, and osteoblasts for assays of multipotential differentiation. The morphological characteristics of ADSCs were observed under an inverted microscope in bright field and phase-contrast ways and a confocal laser scanning microscopy. Moreover, the directional differentiation potential was observed by Oil Red, alkaline phosphatase, von Kossa, and toluidine blue stainings, respectively. The expressions of CD34, CD44, CD45, CD105, and HLA-DR were also detected via flow cytometry. Following to this, ADSCs were induced by angiotensin II and basic fibroblast growth factor for the purpose of directional differentiation towards cardiomyocyte-like cells, and the cells treated with 5-azacytidine were regarded as the control. The results showed that the isolated and cultured ADSCs presented a typical morphology of fusiform shape and also expressed CD44, CD105, but not CD34, CD45, and HLA-DR with assays of flow cytometry. The multi-differentiations to adipocytes, chondrocytes, and osteoblasts confirmed that the isolated cells maintained the stem characteristics generating from adipose tissues. After 4 weeks of induction by angiotensin II, the cells expressed myosin heavy chain, troponin I, and connexin43 by immunocytochemistry staining, but without beating of the cells. This current study indicated that ADSCs possessed the characteristics of mesenchymal stem cells and angiotensin II could induce ADSCs into cardiomyocyte-like cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546871     DOI: 10.1007/s12010-013-0210-6

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  6 in total

1.  Adipose tissue derived mesenchymal stem cells are better respondents to TGFβ1 for in vitro generation of cardiomyocyte-like cells.

Authors:  Anupama Kakkar; Sushmita Bose Nandy; Suchi Gupta; Balram Bharagava; Balram Airan; Sujata Mohanty
Journal:  Mol Cell Biochem       Date:  2019-06-21       Impact factor: 3.396

2.  Fabrication and development of artificial osteochondral constructs based on cancellous bone/hydrogel hybrid scaffold.

Authors:  Kedong Song; Liying Li; Xinyu Yan; Yu Zhang; Ruipeng Li; Yiwei Wang; Ling Wang; Hong Wang; Tianqing Liu
Journal:  J Mater Sci Mater Med       Date:  2016-05-14       Impact factor: 3.896

Review 3.  A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases.

Authors:  Teng Ma; Jiacheng Sun; Zhenao Zhao; Wei Lei; Yueqiu Chen; Xu Wang; Junjie Yang; Zhenya Shen
Journal:  Stem Cell Res Ther       Date:  2017-06-05       Impact factor: 6.832

Review 4.  Advances in regenerative therapy: A review of the literature and future directions.

Authors:  Edward H Ntege; Hiroshi Sunami; Yusuke Shimizu
Journal:  Regen Ther       Date:  2020-02-20       Impact factor: 3.419

Review 5.  Adipose-derived regenerative cells as a promising therapy for cardiovascular diseases: an overview.

Authors:  Shukuro Yamaguchi; Yuki Shimizu; Toyoaki Murohara; Rei Shibata
Journal:  Nagoya J Med Sci       Date:  2022-05       Impact factor: 0.794

6.  Comparison of Sources and Methods for the Isolation of Equine Adipose Tissue-Derived Stromal/Stem Cells and Preliminary Results on Their Reaction to Incubation with 5-Azacytidine.

Authors:  Dagmar S Trachsel; Hannah J Stage; Sebastian Rausch; Susanne Trappe; Katharina Söllig; Gerhard Sponder; Roswitha Merle; Jörg R Aschenbach; Heidrun Gehlen
Journal:  Animals (Basel)       Date:  2022-08-11       Impact factor: 3.231

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.